Welcome to Cardio Deep Dive , a podcast where cutting-edge cardiovascular science meets real-world clinical practice. I’m Dr. Nishith Chandra, a cardiologist, and in each episode we break down the latest advances in heart care—new trials, emerging technologies, innovative procedures, and evolving guidelines—into clear, practical insights. From interventional breakthroughs to preventive cardiology and digital health, this podcast is designed for clinicians,and curious listeners who want to stay ahead in cardiovascular medicine. If the heart fascinates you this podcast is for you.
Cardio Deep Dive
Claim This Podcastby Nishith Chandra
6 episodes
Updated Daily
Accepts GuestsHas Sponsors
Podcast Overview
Welcome to Cardio Deep Dive , a podcast where cutting-edge cardiovascular science meets real-world clinical practice. I’m Dr. Nishith Chandra, a cardiologist, and in each episode we break down the latest advances in heart care—new trials, emerging technologies, innovative procedures, and evolving guidelines—into clear, practical insights. From interventional breakthroughs to preventive cardiology and digital health, this podcast is designed for clinicians,and curious listeners who want to stay ahead in cardiovascular medicine. If the heart fascinates you this podcast is for you.
Language
🇺🇲
Publishing Since
12/17/2025
1 verified contact email on file for Cardio Deep Dive
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
February 7, 2026
Decoding Genetic Basis of Coronary Artery Disease: Can you reduce the risk ?
<p>Coronary artery disease (CAD) is a complex condition resulting from the interplay of behavioral, environmental, and genetic factors. While modifiable risk factors like smoking and hypertension are well-recognized, recent large-scale genomic studies have identified hundreds of genetic variants that significantly influence susceptibility. This inherited basis manifests in two primary forms: rare monogenic variants with large effects (such as familial hypercholesterolemia) and a broad polygenic architecture composed of common variants with small individual effects.</p><p>The integration of polygenic risk scores (PRS) into clinical practice offers a mechanism to refine risk prediction, particularly for younger individuals and those with intermediate clinical risk. Furthermore, genetic insights have validated several contemporary therapeutic targets and prioritized new pathways for drug development. Despite these advances, challenges remain regarding the standardization of genetic scores, equitable access across diverse ancestries, and the determination of cost-effectiveness in routine clinical implementation.</p><p>If you have following burning questions, then this podcast is worth listening.</p><p>1/ What is the importance of genetics in CAD ?</p><p>2/ If family history of CAD is negative, does it confers safety to the offsprings ?</p><p>3/ Can we diagnose the risk of future CAD at birth by genetic tests ?</p><p>4/ If the genetic risk of CAD is high, can we modify it by lifestyle changes ?</p><p>5/ Are there medicines to affect genetic susceptibility for CAD ?</p><p><br></p><p>This podcast is based on the latest article "<strong> The Inherited Basis of Coronary Artery Disease" </strong>by Dr Pradeep Natarajan etal Center for Genomic Medicine and Cardiovascular Research Center, Massachusetts General Hospital, Boston. Published in NEJM.</p><p>N Engl J Med 2026;394:576-87.</p><p>DOI: 10.1056/NEJMra2405153</p>
January 16, 2026
LIMA: The Un Cloggable Artery
<p>This podcast examines the unique <strong>biological resilience</strong> of the <strong>internal mammary artery (IMA)</strong>, which remains remarkably <strong>resistant to atherosclerosis</strong> despite being exposed to the same systemic risks as other vessels. While traditional risk factors drive disease in most arteries, the IMA possesses specialized <strong>endothelial properties</strong>, including high <strong>nitric oxide production</strong> and a robust <strong>internal elastic lamina</strong>, that prevent plaque buildup. Its anatomical structure promotes stable <strong>anterograde blood flow</strong>, fostering an anti-inflammatory environment that preserves vascular health even during the aging process. Because of these protective qualities, the IMA is the <strong>preferred conduit</strong> for bypass surgery, demonstrating superior long-term survival rates compared to vein grafts. By shifting the medical focus from systemic risks to these localized <strong>mechanisms of resistance</strong>, researchers hope to discover <strong>novel therapeutic targets</strong> to treat cardiovascular disease. The text emphasizes that understanding why this specific artery "bounces back" from injury could revolutionize how we address <strong>unmet medical needs</strong> in heart health.</p><p><br></p><p>This podcast is based on the excellent article "<strong> Resilience of the Internal Mammary Artery to Atherogenesis: Shifting From Risk to Resistance to Address Unmet Needs"</strong> by Kraler et al. published in Journal <u>Arteriosclerosis, Thrombosis, and Vascular Biology</u></p><p>Arterioscler Thromb Vasc Biol. 2021;41:2237–2251. DOI: 10.1161/ATVBAHA.121.316256 </p>
December 18, 2025
Vulnerable Plaque: The new treatment target !
<p>Welcome to <strong>Cardio Deep Dive</strong> latest episode. In today’s episode we focus on <u><strong>vulnerable plaque</strong></u>: the high-risk atherosclerotic lesion characterized by a thin fibrous cap, large lipid core and intense inflammation that predisposes to rupture, thrombosis, and acute coronary syndromes despite often minimal stenosis. We’ll explore its pathophysiology, clinical significance, and evolving imaging and management strategies to better prevent sudden cardiac events.</p>
6 total episodes available
Deep-dive analytics for Cardio Deep Dive
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Cardio Deep Dive?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Information about guest appearances is not available.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.